Report Detail

Request for Sample of this report

Other Global Primary Human Cell Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4538621
    • |
  • 10 July, 2023
    • |
  • Global
    • |
  • 114 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global Primary Human Cell market size was valued at USD 617.4 million in 2022 and is forecast to a readjusted size of USD 1060.7 million by 2029 with a CAGR of 8.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The primary cells have been isolated for a short time and have not undergone the immortalization process. Their biological characteristics have not changed much, and they still maintain the original genetic characteristics, which can better reflect the growth status of cells in vivo, so as to obtain physiological functions in vivo. The closer data is very suitable for experimental research such as drug testing, cell differentiation and transformation.
Primary cells refer to the initial cells derived from living tissues and prepared by specific separation methods.
This report is a detailed and comprehensive analysis for global Primary Human Cell market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Primary Human Cell market size and forecasts, in consumption value ($ Million), 2018-2029
Global Primary Human Cell market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Primary Human Cell market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Primary Human Cell market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Primary Human Cell
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Primary Human Cell market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Procell, Lonza, ATCC and Cell Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Primary Human Cell market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Newborn
Aldult
Market segment by Application
Laboratory
Pharmaceutical Companies
Other
Market segment by players, this report covers
Thermo Fisher Scientific
Procell
Lonza
ATCC
Cell Biologics
CellSystems GmbH
Corning
Creative Bioarray
FUJIFILM Irvine Scientific
GE Healthcare
Irvine Scientific
Cyagen
MatTek Ltd
Merck
Promocell GmbH
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Primary Human Cell product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Primary Human Cell, with revenue, gross margin and global market share of Primary Human Cell from 2018 to 2023.
Chapter 3, the Primary Human Cell competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Primary Human Cell market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Primary Human Cell.
Chapter 13, to describe Primary Human Cell research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Primary Human Cell
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Primary Human Cell by Type
    • 1.3.1 Overview: Global Primary Human Cell Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Primary Human Cell Consumption Value Market Share by Type in 2022
    • 1.3.3 Newborn
    • 1.3.4 Aldult
  • 1.4 Global Primary Human Cell Market by Application
    • 1.4.1 Overview: Global Primary Human Cell Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Laboratory
    • 1.4.3 Pharmaceutical Companies
    • 1.4.4 Other
  • 1.5 Global Primary Human Cell Market Size & Forecast
  • 1.6 Global Primary Human Cell Market Size and Forecast by Region
    • 1.6.1 Global Primary Human Cell Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Primary Human Cell Market Size by Region, (2018-2029)
    • 1.6.3 North America Primary Human Cell Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Primary Human Cell Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Primary Human Cell Market Size and Prospect (2018-2029)
    • 1.6.6 South America Primary Human Cell Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Primary Human Cell Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Primary Human Cell Product and Solutions
    • 2.1.4 Thermo Fisher Scientific Primary Human Cell Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.2 Procell
    • 2.2.1 Procell Details
    • 2.2.2 Procell Major Business
    • 2.2.3 Procell Primary Human Cell Product and Solutions
    • 2.2.4 Procell Primary Human Cell Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Procell Recent Developments and Future Plans
  • 2.3 Lonza
    • 2.3.1 Lonza Details
    • 2.3.2 Lonza Major Business
    • 2.3.3 Lonza Primary Human Cell Product and Solutions
    • 2.3.4 Lonza Primary Human Cell Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Lonza Recent Developments and Future Plans
  • 2.4 ATCC
    • 2.4.1 ATCC Details
    • 2.4.2 ATCC Major Business
    • 2.4.3 ATCC Primary Human Cell Product and Solutions
    • 2.4.4 ATCC Primary Human Cell Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 ATCC Recent Developments and Future Plans
  • 2.5 Cell Biologics
    • 2.5.1 Cell Biologics Details
    • 2.5.2 Cell Biologics Major Business
    • 2.5.3 Cell Biologics Primary Human Cell Product and Solutions
    • 2.5.4 Cell Biologics Primary Human Cell Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Cell Biologics Recent Developments and Future Plans
  • 2.6 CellSystems GmbH
    • 2.6.1 CellSystems GmbH Details
    • 2.6.2 CellSystems GmbH Major Business
    • 2.6.3 CellSystems GmbH Primary Human Cell Product and Solutions
    • 2.6.4 CellSystems GmbH Primary Human Cell Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 CellSystems GmbH Recent Developments and Future Plans
  • 2.7 Corning
    • 2.7.1 Corning Details
    • 2.7.2 Corning Major Business
    • 2.7.3 Corning Primary Human Cell Product and Solutions
    • 2.7.4 Corning Primary Human Cell Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Corning Recent Developments and Future Plans
  • 2.8 Creative Bioarray
    • 2.8.1 Creative Bioarray Details
    • 2.8.2 Creative Bioarray Major Business
    • 2.8.3 Creative Bioarray Primary Human Cell Product and Solutions
    • 2.8.4 Creative Bioarray Primary Human Cell Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Creative Bioarray Recent Developments and Future Plans
  • 2.9 FUJIFILM Irvine Scientific
    • 2.9.1 FUJIFILM Irvine Scientific Details
    • 2.9.2 FUJIFILM Irvine Scientific Major Business
    • 2.9.3 FUJIFILM Irvine Scientific Primary Human Cell Product and Solutions
    • 2.9.4 FUJIFILM Irvine Scientific Primary Human Cell Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 FUJIFILM Irvine Scientific Recent Developments and Future Plans
  • 2.10 GE Healthcare
    • 2.10.1 GE Healthcare Details
    • 2.10.2 GE Healthcare Major Business
    • 2.10.3 GE Healthcare Primary Human Cell Product and Solutions
    • 2.10.4 GE Healthcare Primary Human Cell Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 GE Healthcare Recent Developments and Future Plans
  • 2.11 Irvine Scientific
    • 2.11.1 Irvine Scientific Details
    • 2.11.2 Irvine Scientific Major Business
    • 2.11.3 Irvine Scientific Primary Human Cell Product and Solutions
    • 2.11.4 Irvine Scientific Primary Human Cell Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Irvine Scientific Recent Developments and Future Plans
  • 2.12 Cyagen
    • 2.12.1 Cyagen Details
    • 2.12.2 Cyagen Major Business
    • 2.12.3 Cyagen Primary Human Cell Product and Solutions
    • 2.12.4 Cyagen Primary Human Cell Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Cyagen Recent Developments and Future Plans
  • 2.13 MatTek Ltd
    • 2.13.1 MatTek Ltd Details
    • 2.13.2 MatTek Ltd Major Business
    • 2.13.3 MatTek Ltd Primary Human Cell Product and Solutions
    • 2.13.4 MatTek Ltd Primary Human Cell Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 MatTek Ltd Recent Developments and Future Plans
  • 2.14 Merck
    • 2.14.1 Merck Details
    • 2.14.2 Merck Major Business
    • 2.14.3 Merck Primary Human Cell Product and Solutions
    • 2.14.4 Merck Primary Human Cell Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Merck Recent Developments and Future Plans
  • 2.15 Promocell GmbH
    • 2.15.1 Promocell GmbH Details
    • 2.15.2 Promocell GmbH Major Business
    • 2.15.3 Promocell GmbH Primary Human Cell Product and Solutions
    • 2.15.4 Promocell GmbH Primary Human Cell Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Promocell GmbH Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Primary Human Cell Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Primary Human Cell by Company Revenue
    • 3.2.2 Top 3 Primary Human Cell Players Market Share in 2022
    • 3.2.3 Top 6 Primary Human Cell Players Market Share in 2022
  • 3.3 Primary Human Cell Market: Overall Company Footprint Analysis
    • 3.3.1 Primary Human Cell Market: Region Footprint
    • 3.3.2 Primary Human Cell Market: Company Product Type Footprint
    • 3.3.3 Primary Human Cell Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Primary Human Cell Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Primary Human Cell Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Primary Human Cell Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Primary Human Cell Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Primary Human Cell Consumption Value by Type (2018-2029)
  • 6.2 North America Primary Human Cell Consumption Value by Application (2018-2029)
  • 6.3 North America Primary Human Cell Market Size by Country
    • 6.3.1 North America Primary Human Cell Consumption Value by Country (2018-2029)
    • 6.3.2 United States Primary Human Cell Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Primary Human Cell Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Primary Human Cell Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Primary Human Cell Consumption Value by Type (2018-2029)
  • 7.2 Europe Primary Human Cell Consumption Value by Application (2018-2029)
  • 7.3 Europe Primary Human Cell Market Size by Country
    • 7.3.1 Europe Primary Human Cell Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Primary Human Cell Market Size and Forecast (2018-2029)
    • 7.3.3 France Primary Human Cell Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Primary Human Cell Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Primary Human Cell Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Primary Human Cell Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Primary Human Cell Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Primary Human Cell Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Primary Human Cell Market Size by Region
    • 8.3.1 Asia-Pacific Primary Human Cell Consumption Value by Region (2018-2029)
    • 8.3.2 China Primary Human Cell Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Primary Human Cell Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Primary Human Cell Market Size and Forecast (2018-2029)
    • 8.3.5 India Primary Human Cell Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Primary Human Cell Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Primary Human Cell Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Primary Human Cell Consumption Value by Type (2018-2029)
  • 9.2 South America Primary Human Cell Consumption Value by Application (2018-2029)
  • 9.3 South America Primary Human Cell Market Size by Country
    • 9.3.1 South America Primary Human Cell Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Primary Human Cell Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Primary Human Cell Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Primary Human Cell Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Primary Human Cell Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Primary Human Cell Market Size by Country
    • 10.3.1 Middle East & Africa Primary Human Cell Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Primary Human Cell Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Primary Human Cell Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Primary Human Cell Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Primary Human Cell Market Drivers
  • 11.2 Primary Human Cell Market Restraints
  • 11.3 Primary Human Cell Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Primary Human Cell Industry Chain
  • 12.2 Primary Human Cell Upstream Analysis
  • 12.3 Primary Human Cell Midstream Analysis
  • 12.4 Primary Human Cell Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Primary Human Cell. Industry analysis & Market Report on Primary Human Cell is a syndicated market report, published as Global Primary Human Cell Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Primary Human Cell market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,777.04
    		4,165.56
    		5,554.08
    		3,246.84
    		4,870.26
    		6,493.68
    		535,084.80
    		802,627.20
    		1,070,169.60
    		290,440.80
    		435,661.20
    		580,881.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo